Reaction
Mucoepidermoid Carcinoma Of Salivary Gland reporting signals
As of the last recalculation, Mucoepidermoid Carcinoma Of Salivary Gland appears in 57 FAERS reports alongside 4 co-occurring drug terms. The strongest observed disproportionality signal is ALEMTUZUMAB (PRR 537.6).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Alemtuzumab | 19 | 537.6 | 538.1 |
| Bleomycin Sulfate | 9 | 377.6 | 377.9 |
| Melphalan | 15 | 326.4 | 326.7 |
| Melphalan Hydrochloride | 15 | 296.1 | 296.3 |